Secret War on Sneaky Lung Bugs: NIH Hides Contract Bids
Published Date: 4/4/2025
Notice
Summary
The National Institute of Allergy and Infectious Diseases is holding a private meeting on May 2, 2025, to review contract proposals for new treatments targeting tough infections called non-tuberculosis mycobacterial infections. This meeting affects researchers and companies competing for funding to develop these medical solutions. The review helps decide who gets money to create better treatments, all while keeping sensitive info under wraps.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
Closed Review Protects Proprietary Proposals
The National Institute of Allergy and Infectious Diseases will hold a closed meeting on May 2, 2025, from 11:00 a.m. to 1:00 p.m. to review contract proposals. The meeting is closed under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, patentable material, and personal information of proposal submitters.
NIH Panel Will Evaluate SBIR NTM Proposals
A special emphasis panel (HHS-NIH-CDC-SBIR PHS 2025-1, Phase I/II, Topic 144) will review and evaluate contract proposals on May 2, 2025, to decide awards for developing treatments for non-tuberculosis mycobacterial (NTM) infections. The panel's review determines which researchers and companies competing for this SBIR funding may receive contracts.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-15565, Proposed Collection; 60-Day Comment Request, Data Use Certification for the NIH Brain Development Cohorts (NBDC) Data Hub, (National Institute on Drug Abuse)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. The purpose of this revision is to update instructions for the Research Data Use Statement and the Progress Report, and to add new instructions for attesting to National Institute of Standards & Technology (NIST) security compliance, and for a Project Close-out at the time of project completion. Burden levels remain unchanged.
2026-14966, Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a new Ebola vaccine invention for companies to license and develop quickly. This vaccine targets the Bundibugyo virus and promises fast and lasting protection, helping stop outbreaks in Central Africa. Businesses interested in licensing should act soon to bring this life-saving tech to market and can contact NIH for details.
Previous / Next Documents
Previous: 2025-05828, Notice Initiating Docket(s) for Recent Postal Service Competitive Negotiated Service Agreement Filings
The Postal Service just filed new deals for Priority Mail and USPS Ground services, and the Postal Regulatory Commission is officially opening dockets to review them. These deals could change prices and how mail moves, affecting businesses and customers who use these services. Keep an eye out because these changes might start soon and could impact shipping costs.
Next: 2025-05832, National Institute of General Medical Sciences; Notice of Closed Meetings
The National Institute of General Medical Sciences is holding two secret virtual meetings in July 2025 to review important grant applications. These closed meetings protect private info and trade secrets while deciding who gets research funding. Scientists and research groups applying for grants should watch for results soon, as these reviews impact future funding and projects.